Neuroscience and biomedical engineering startup BrainBridge has announced its ambitious goal to develop the world’s first head transplant system.
The company, which had been operating in stealth mode, revealed that it is integrating advanced robotics and artificial intelligence to execute complete head and face transplantation procedures, a concept reminiscent of science fiction but now inching closer to reality.
BrainBridge’s pioneering technology aims to offer new hope to patients suffering from untreatable conditions such as stage-4 cancer, paralysis, and neurodegenerative diseases like Alzheimer’s and Parkinson’s. The procedure involves transplanting a patient’s head onto a healthy, brain-dead donor body, with the aim of preserving consciousness, memories, and cognitive abilities.
The company plans to employ high-speed robotic systems to prevent brain cell degradation and ensure seamless compatibility between the transplanted head and donor body. Real-time molecular-level imaging and advanced AI algorithms will guide the precise reconnection of the spinal cord, nerves, and blood vessels.
BrainBridge’s integrated robotics platform features two autonomous surgical robots designed to perform simultaneous surgeries on two bodies within a single setup. The company’s proprietary chemical adhesive, polyethylene glycol, will aid in reconnecting severed neurons. Additionally, a specialized implant placed in the epidural space behind the spine will promote neuron repair, enabling the patient’s brain to form neural connections with the new body. The BCI-equipped BrainBridge Head Band will allow patients to communicate their needs during recovery.
Scientific foundations and future plans
“Every step of the BrainBridge concept has been carefully thought out based on extensive scientific research,” said Hashem Al-Ghaili, project lead at BrainBridge. “Our goal is to push the boundaries of medical science and provide innovative solutions for those battling life-threatening conditions.”
Exiting stealth mode, BrainBridge aims to attract top talent in science and engineering to overcome upcoming challenges and bring this life-changing technology to patients. The company is currently focused on refining its initial concept through comprehensive feasibility studies using advanced AI-powered simulation models. These simulations will help refine the surgical process, predict outcomes, and optimize patient recovery protocols.
Al-Ghaili shared that if the feasibility studies yield promising results and the team is fully assembled, the roadmap to conducting the first surgery could be realized within eight years.